A Case Report: Fatal Case of Disseminated Tuberculosis in a 24-year-old Male Patient with Crohn’s Disease
DOI:
https://doi.org/10.38179/ijcr.v1i1.2Keywords:
intestinal TB, Crohn's Disease, Concomitant diagnosis, active pulmonary TB, disseminated TB, iTB and CD, case reportAbstract
Introduction: Cohn’s disease (CD) is an idiopathic disorder involving the GI tract. The differential diagnosis of CD is broad and includes infectious colitis, ulcerative colitis intestinal TB (iTB), etc. Due to the lack of standards in a definitive diagnosis, discrimination between iTB and CD has long been a diagnostic challenge.
Case presentation: A 24-year-old male patient, known to have Crohn’s disease, treated with daily prednisone 60 mg and mesalamine since 1 week (due to a flare-up), presented for 2 days history of severe exacerbating diffuse abdominal pain, along with generalized weakness, weight loss, watery diarrhea, vomiting, decreased oral intake, and high-grade fever (39 °C). An urgent abdominopelvic CT scan with IV contrast showed significant pneumo-peritoneum and minimal fluid distributed inside the abdomen, denoting bowel perforation. The patient underwent an urgent laparotomy. Intraoperative findings were an abdominal cavity full of fecal material, multiple small bowel perforations, and entero- enteric fistulas. 1.5 meters of the small intestine was resected. Pathology showed iTB. TB PCR of deep tracheal aspirate was positive as well. The patient was started on anti-TB treatment for disseminated tuberculosis affecting the lungs and GI tract. Unfortunately, the patient developed a septic pulmonary embolism on day 7 post-op and was announced dead on day 9.
Conclusion: Our case emphasizes that the two chronic granulomatous diseases (CD and iTB) have similarities that make the distinction between them difficult and yet crucial because of possible repercussions of a misdiagnosis. It also highlights the importance of latent TB screening before starting the confirmed CD immunosuppressive treatment especially in underdeveloped countries, as the patient could have a reactivation of latent TB upon initiation of immunosuppressive therapy.
References
Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol. 2008 Jun;8(6):458-66. https://doi.org/10.1038/nri2340. PMID: 18500230.
Tontini GE, Vecchi M, Pastorelli L, Neurath MF, Neumann H. Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives. World J Gastroenterol. 2015 Jan 7;21(1):21-46. https://doi.org/10.3748/wjg.v21.i1.21 PMID: 25574078; PMCID: PMC4284336.
Zhou D, Ouyang Q, Xiong M, Zhang Y. Crohn's disease with positive Ziehl-Neelsen stain: Three case reports. Niger J Clin Pract. 2018 Oct;21(10):1387-1390. PMID: 30297577.
Ng SC, Hirai HW, Tsoi KK, Wong SH, Chan FK, Sung JJ, Wu JC. Systematic review with meta-analysis: accuracy of interferon-gamma releasing assay and anti-Saccharomyces cerevisiae antibody in differentiating intestinal tuberculosis from Crohn's disease in Asians. J Gastroenterol Hepatol. 2014 Sep;29(9):1664-70. https://doi.org/10.1111/jgh.12645. PMID: 24910240.
Almadi MA, Ghosh S, Aljebreen AM. Differentiating intestinal tuberculosis from Crohn's disease: a diagnostic challenge. Am J Gastroenterol. 2009 Apr;104(4):1003-12. https://doi.org/10.1038/ajg.2008.162. Epub 2009 Feb 24. PMID: 19240705.
Ma JY, Tong JL, Ran ZH. Intestinal tuberculosis and Crohn's disease: challenging differential diagnosis. J Dig Dis. 2016 Mar;17(3):155-61. https://doi.org/10.1111/1751-2980.12324. PMID: 26854750.
Patel N, Amarapurkar D, Agal S, Baijal R, Kulshrestha P, Pramanik S, Gupte P. Gastrointestinal luminal tuberculosis: establishing the diagnosis. J Gastroenterol Hepatol. 2004 Nov;19(11):1240-6. https://doi.org/10.1111/j.1440-1746.2004.03485.x. PMID: 15482529.
Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG Clinical Guideline: Management of Crohn's Disease in Adults. Am J Gastroenterol. 2018 Apr;113(4):481-517. https://doi.org/10.1038/ajg.2018.27. Epub 2018 Mar 27. Erratum in: Am J Gastroenterol. 2018 Jul;113(7):1101. PMID: 29610508.
Miller M, Vu KN, Zemek A, Shelton A, Kin C. TB or Not TB: Crohn's Disease, Peritoneal Tuberculosis, or Both? Dig Dis Sci. 2019 Jun;64(6):1432-1435. https://doi.org/10.1007/s10620-018-5334-7. PMID: 30334111.
Marshall JB. Tuberculosis of the gastrointestinal tract and peritoneum. Am J Gastroenterol. 1993 Jul;88(7):989-99. PMID: 8317433.
Cheng W, Zhang S, Li Y, Wang J, Li J. Intestinal tuberculosis: clinico-pathological profile and the importance of a high degree of suspicion. Trop Med Int Health. 2019 Jan;24(1):81-90. https://doi.org/10.1111/tmi.13169. Epub 2018 Nov 8. PMID: 30338607.
Papadakis KA, Targan SR. Tumor necrosis factor: biology and therapeutic inhibitors. Gastroenterology. 2000 Oct;119(4):1148-57. https://doi.org/10.1053/gast.2000.18160. PMID: 11040201.
Ince AT, Güneş P, Senateş E, Sezikli M, Tiftikçi A, Ovünç O. Can an immunohistochemistry method differentiate intestinal tuberculosis from Crohn's disease in biopsy specimens? Dig Dis Sci. 2011 Apr;56(4):1165-70. https://doi.org/10.1007/s10620-010-1399-7. Epub 2010 Sep 8. PMID: 20824497.
Jin XJ, Kim JM, Kim HK, Kim L, Choi SJ, Park IS, Han JY, Chu YC, Song JY, Kwon KS, Kim EJ. Histopathology and TB-PCR kit analysis in differentiating the diagnosis of intestinal tuberculosis and Crohn's disease. World J Gastroenterol. 2010 May 28;16(20):2496-503. https://doi.org/10.3748/wjg.v16.i20.2496. PMID: 20503449; PMCID: PMC2877179.
Seo H, Lee S, So H, Kim D, Kim SO, Soh JS, Bae JH, Lee SH, Hwang SW, Park SH, Yang DH, Kim KJ, Byeon JS, Myung SJ, Yang SK, Ye BD. Temporal trends in the misdiagnosis rates between Crohn's disease and intestinal tuberculosis. World J Gastroenterol. 2017 Sep 14;23(34):6306-6314. https://doi.org/10.3748/wjg.v23.i34.6306. PMID: 28974897; PMCID: PMC5603497.
Published
How to Cite
Issue
Section
Copyright (c) 2020 International Journal of Clinical Research
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.